Bausch Health Companies (BHC) Cash from Financing Activities (2009 - 2026)

Bausch Health Companies has reported Cash from Financing Activities for 18 years, with the latest figure at -$49.0 million in Q2 2026.

• Quarterly Cash from Financing Activities fell 113.69% year-over-year to -$49.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.1 billion (down 1121.3% YoY) and the FY2025 annual result came in at -$742.0 million, up 14.52% from the prior year.
• Cash from Financing Activities rose to -$49.0 million in Q2 2026 per BHC's latest filing, from -$100.0 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $1.8 billion in Q3 2023 and troughed at -$719.0 million in Q3 2025.
• A 5-year average of -$42.1 million and a median of -$131.0 million in 2023 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities surged 5144.44% in 2023, then slumped 376.47% in 2025.
• Over 5 years, Cash from Financing Activities stood at -$276.0 million in 2022, then jumped by 71.38% to -$79.0 million in 2023, then surged by 207.59% to $85.0 million in 2024, then plunged by 376.47% to -$235.0 million in 2025, then jumped by 79.15% to -$49.0 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$49.0 million, -$100.0 million, and -$235.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.